Whelix (formerly MitoAI)

Hiring activelyHealth & bio · Lab toolsAI-native

Intelligent robotics for cell culture automation. Whelix combines AI agents with lab robotics so your biology runs 24/7 — protocols generated from plain language, executed autonomously, monitored live.

whelix.com · Boston, MA

Source Form DCIK 0002049511as of 2026-11-13

Funding event

The round itself, as filed
Inferred stageSeed
Sold of offered$5.4M of $8.1M
Filed2026-11-04
Days since filing9
Exemption claimed
Rule 506(b)
First-ever Form D
No
Date of first sale
2026-10-22
Investors

No investors named: Form D does not list them

Exemption is the box the issuer checked, not our judgement.

Officers on the filing

Names and roles as filed; addresses are never stored
  • Bingda LiExecutive Officer · Director
  • Guanlin LiExecutive Officer
  • Jeff KnoxDirector
  • Xinyu WangExecutive Officer · Director
Form D item 3. Related-person addresses stay in the raw filing and appear in no export, API or alert.

Health flags

Three flags, each with the raw inputs behind it · as of 2026-11-13
UndersubscribedNot flagged$5.4M of $8.1M sold0.7 months since first sale
Prior raiseNot flaggedRaised $5.4M against a prior $200K$200K prior raise, filed 2024-12-20
AmendedNot flaggedNo amendmentNo D/A on file

Open roles

On the employer's own careers page · checked 2026-11-05
9

Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.

Roles link to the employer's own page; Noctura shows titles only.

Also raised in Health & bio

Same sector, 28 days to 2026-11-15
OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet

103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.

Every Monday

The week, written up

Start Signals